Dyne Therapeutics, Inc. (DYN) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.19B | +71.7% |
| 2024 | $691.23M | +318.7% |
| 2023 | $165.08M | -46.1% |
| 2022 | $306.32M | -28.0% |
| 2021 | $425.66M | +20.5% |
| 2020 | $353.33M | +2049.8% |
| 2019 | $16.44M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $1.19B | +71.7% |
| 2024 | $691.23M | +318.7% |
| 2023 | $165.08M | -46.1% |
| 2022 | $306.32M | -28.0% |
| 2021 | $425.66M | +20.5% |
| 2020 | $353.33M | +2049.8% |
| 2019 | $16.44M | — |